Medication
Refresh Lacri-Lube
DIN 00210889 · Abbvie Corporation
What it is
- Active ingredients
- Mineral Oil — 42.5%
- White Petrolatum — 57.3%
- Form and route
- Ointment · Ophthalmic
- Schedule
- NON-PRESCRIPTION DRUGS
- Authorised since
- 1989-12-31
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
No other medication authorised in Canada shares this active ingredient.
Health Canada groups products by their active ingredients. No other marketed product shares this one’s group, which usually means it is still the only authorised version — not that alternatives were hidden or missed.
Watch this medication
Ontario Drug Benefit coverage
As of 31 July 2026Limited Use benefit Part XII
Ontario lists this product as a Limited Use benefit — Part XII of the Formulary/CDI. ODB pays for it only in the specific circumstances Ontario sets out against it, and the prescription has to carry a Limited Use code from the prescriber.
The criteria are set by Ontario and are not reproduced here — they are a matter for the prescriber.
- What ODB pays per unit
- $7.9000
This is what the Ontario Drug Benefit program reimburses a pharmacy for one unit, as of 31 July 2026. A deductible and a co-payment sit on top of it and differ by program — ODB, the Trillium Drug Program and the seniors co-payment each work differently — so it is not the figure anyone is charged at a counter. It also says nothing about private, workplace or federal coverage.
Source: Ontario Ministry of Health — ODB Formulary. Data current as of 2026-07-28. Ontario only. Formulary edition 4342, effective 31 July 2026.
How it is classified
- Anatomical main group
- Sensory organs
- ATC code
- S01XA20
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of S01XA20, see the WHO ATC/DDD Index.
Recalls and safety alerts
As of 12 August 2026Health Canada has published a recall or safety alert naming this product. Read it on Health Canada’s own site, and speak to a pharmacist before changing anything about how you take this medication.
Refresh Lacri-Lube Ophthalmic ointment: Sterility concerns
Health Canada says: Do not use the affected product. Return it to your local pharmacy for proper disposal.Seek medical attention if you have used this product and are experiencing signs of infection, such as eye pain and discharge, fever, or facial pain or pressure.Consult a health care professional if you have used this product and have health concerns.Contact AbbVie Corporation of Canada by calling 1-888-704-8270 or emailing service@abbvie.com if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.
Matched on the product name at the start of the notice.
Archived by Health Canada
1 older notice naming this product has been archived. These are a record of what happened, not current warnings.
Refresh Lacri-Lube (2015-08-28)
Matched on the product name at the start of the notice.
This list may be incomplete. Health Canada’s recalls data carries no DIN, so notices are matched on wording alone. Search Health Canada recalls for Refresh Lacri-Lube → How RxMonitor matches recalls, and how often it fails
Source: Health Canada — Recalls and Safety Alerts. Data current as of 2026-08-12. Matched on product name, not on DIN — the feed carries none.